StockWatch
·
Biotechnology: Pharmaceutical Preparations
Corporate ActionMay 27, 2026, 05:06 PM

Dominari Holdings offers warrant options, expects $3.67M proceeds

AI Summary

Dominari Holdings Inc. entered into inducement agreements with certain Series B warrant holders to reduce market overhang from outstanding warrants. The offer provided two options: either exercise warrants for cash at a reduced price of $2.50 per share, or exchange warrants for common stock at a 10:3 ratio. The company anticipates receiving approximately $3.67 million in gross proceeds from cash exercises and issuing about 150,000 shares for exchanges, which is expected to reduce the number of outstanding Series B warrants to approximately 1.2 million.

Key Highlights

  • Dominari Holdings entered inducement agreements with Series B warrant holders to reduce market overhang.
  • Original Series B warrants covered up to 3,133,880 shares at an exercise price of $4.22 per share.
  • Holders could exercise for cash at a reduced price of $2.50 per share (Option A).
  • Alternatively, holders could exchange 10 unexercised warrants for 3 common shares (Option B).
  • The company expects to receive approximately $3.67 million in gross proceeds from Option A elections.
  • Approximately 150,000 shares of Common Stock are expected to be issued from Option B elections.
  • Following these transactions, about 1.2 million Series B warrants are expected to remain outstanding.